|
|
Volumn 9 Suppl 3, Issue , 2008, Pages
|
|
Risk in CNS drug discovery: focus on treatment of Alzheimer's disease.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL MARKER;
ALZHEIMER DISEASE;
ANIMAL;
CENTRAL NERVOUS SYSTEM;
DEGENERATIVE DISEASE;
DISEASE MODEL;
DRUG DEVELOPMENT;
DRUG EFFECT;
ECONOMICS;
HUMAN;
METABOLISM;
METHODOLOGY;
PATHOLOGY;
REVIEW;
RISK FACTOR;
ALZHEIMER DISEASE;
ANIMALS;
BIOLOGICAL MARKERS;
CENTRAL NERVOUS SYSTEM;
DISEASE MODELS, ANIMAL;
DRUG DISCOVERY;
HUMANS;
NEURODEGENERATIVE DISEASES;
RISK FACTORS;
MLCS;
MLOWN;
|
|
EID: 85047282978
PISSN: None
EISSN: 14712202
Source Type: Journal
DOI: 10.1186/1471-2202-9-S3-S1 Document Type: Review |
|
Times cited : (2)
|
|
References (7)
|
